Items without sitelinks
From determinar.ia.br - Determine suas informações
Showing below up to 50 results in range #25,951 to #26,000.
- Butyrylcholinesterase deficiency (Q86859)
- Metabolic disease involving other neurotransmitter deficiency (Q86858)
- Nonunion of fracture, tarsus (Q86857)
- Brain stem dysplasia (Q86856)
- Agenesis of lung, unilateral (Q86855)
- Myotonia of pupil (Q86854)
- Agenesis of lung, bilateral (Q86853)
- Acute tubulo-interstitial nephritis due to drugs, biological agents or toxins (Q86852)
- Acute tubulo-interstitial nephritis due to infectious agent (Q86851)
- Nonunion of fracture, toes (Q86850)
- Acute streptococcal pharyngitis (Q86849)
- Unintentionally struck by projectile from verey pistol or flare (Q86848)
- Nonunion of fracture, metatarsus (Q86847)
- Acute tubulo-interstitial nephritis associated with immunological disorders (Q86846)
- Acute urate nephropathy (Q86845)
- Nonunion of fracture, other joints in foot (Q86844)
- Unintentionally struck by projectile from other gas, air or spring operated gun discharge (Q86843)
- Unintentionally struck by projectile from other weapon (Q86842)
- Sequelae of muscle injury of neck (Q86841)
- Unintentionally struck by projectile from spring-operated BB gun (Q86840)
- Iridoplegia (Q86839)
- Unintentionally struck by projectile from paintgun (Q86838)
- Hippus (Q86837)
- Congenital mydriasis (Q86836)
- Neurodegeneration with brain iron accumulation (Q86835)
- Secondary iron overload (Q86834)
- Myeloid metaplasia (Q86833)
- Neonatal haemochromatosis (Q86832)
- Myosis (Q86831)
- Acquired hemochromatosis (Q86830)
- Microcytic anaemia with liver iron overload (Q86829)
- Atransferrinaemia (Q86828)
- Mydriasis (Q86827)
- Intentional self-harm by exposure to or harmful effects of lysergide (Q86826)
- Intentional self-harm by exposure to or harmful effects of unspecified psychodysleptics or hallucinogens (Q86825)
- Fetus or newborn affected by other forms of placental separation (Q86824)
- Intentional self-poisoning by and exposure to narcotics and psychodysleptics or hallucinogens, not elsewhere classified (Q86823)
- Intentional self-harm by exposure to or harmful effects of other psychodysleptics or hallucinogens (Q86822)
- Splenic primary panhaematopenia (Q86821)
- Pneumonia in ascariasis (Q86820)
- Intentional self-harm by exposure to or harmful effects of synthetic cannabinoids (Q86819)
- Chilblain lupus erythematosus (Q86818)
- Intentional self-harm by exposure to or harmful effects of cannabis (Q86817)
- Ehlers-Danlos syndrome, rare variants (Q86816)
- Endophthalmitis in ascariasis (Q86815)
- Distal 17p13.3 deletion (Q86814)
- Gamna disease (Q86813)
- Fetus or newborn affected by placental dysfunction, not otherwise specified (Q86812)
- Brittle diabetes mellitus (Q86811)
- 17p12-p11.2 deletion (Q86810)
